We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Drug Strategy Could Help the Brain After Exposure to Toxic Pollutant
News

Drug Strategy Could Help the Brain After Exposure to Toxic Pollutant

Drug Strategy Could Help the Brain After Exposure to Toxic Pollutant
News

Drug Strategy Could Help the Brain After Exposure to Toxic Pollutant

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Drug Strategy Could Help the Brain After Exposure to Toxic Pollutant"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

New research shows that exposure to the industrial byproduct TCDD in utero could cause the brain’s immune system to go array later in life, damaging important brain circuits, and potentially giving rise to neurodevelopmental disorders, such as autism and ADHD. TCDD is primarily released into the environment by vehicle exhaust and burning wood and low levels of the toxin are found in air, soil, and food. The most common way people are exposed is through meat, dairy, and fish.


In the same study, recently published in the journal Brain, Behavior, and Immunity, researchers also found that pharmacological manipulation could restore the function of microglia, important cells in the brain’s immune system. “This suggests that defects in microglia function resulting from prenatal exposures can be reversed later in life, indicating a possible additional therapeutic avenue for neurodevelopmental disorders,” said Rebecca Lowery, Ph.D., assistant research professor in the Del Monte Institute for Neuroscience at the University of Rochester, and co-first author of the study.


The research, which was conducted in mice, showed that when the brains of males were exposed to TCDD in utero, it caused inflammation which cause microglia to go array when responding to injury. While the microglia themselves appeared healthy, the cells became over activated while responding to injury in a way that could damage important brain circuits. But investigators found that by using the drug Pexidartinib (PLX3397) they could ‘shut-off’ the hyper-responsive microglia and those were replaced by new microglia that functioned normally.


This work offers new clues to when exposure to TCDD is most dangerous. Past research has found that adults exposed to TCDD did not have inflammation in the brain and there was no impact on microglia function. “Microglia are outside of the brain during pregnancy,” said Ania Majewska, Ph.D., lead author on this study. “But after birth they are protected, possibly by the blood brain barrier, this barrier may be what prevents the harmful effects of TCDD from entering the brain.” Researchers now want to understand if other environmental exposures impact microglia similarly, and whether these changes lead to long-term alterations in brain circuitry and function.


Reference: Lowery RL, Latchney SE, Peer RP, et al. Gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin primes cortical microglia to tissue injury. Brain, Behavior, and Immunity. 2022;101:288-303. doi:10.1016/j.bbi.2022.01.013


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement